SCA Pharma, an FDA-registered outsourcing facility, plans to expand its sterile pharmaceutical manufacturing facility by 40% as a result of continued growth during the past 5 years. The company currently operates two sterile pharmaceutical manufacturing facilities located in Windsor, Connecticut, and Little Rock, Arkansas; the planned expansion would increase the size of the Windsor facility to approximately 150,000 square feet with the ability to add state-of-the-art automation, compounding capability, and technical employees to manufacture critical medicines.

SCA Pharma